Literature DB >> 24332456

Public opinion of drug treatment policy: exploring the public's attitudes, knowledge, experience and willingness to pay for drug treatment strategies.

C Matheson1, M Jaffray2, M Ryan3, C M Bond4, K Fraser5, M Kirk5, D Liddell6.   

Abstract

BACKGROUND: Research evidence is strong for opiate replacement treatment (ORT). However, public opinion (attitudes) can be at odds with evidence. This study explored the relationships between, attitudes, knowledge of drugs and a range of socio-demographic variables that potentially influence attitude. This is relevant in the current policy arena in which a major shift from harm reduction to, rehabilitation is underway.
METHODS: A cross sectional postal questionnaire survey in Scotland was conducted where the drug, treatment strategy has changed from harm-reduction to recovery-based. A random sample (N=3000), of the general public, >18 years, and on the electoral register was used. The questionnaire was largely structured with tick box format but included two open questions for qualitative responses. Valuation was measured using the economic willingness-to-pay (WTP) method.
RESULTS: The response rate was 38.1% (1067/2803). Less than 10% had personal experience of drug, misuse but 16.7% had experience of drug misuse via a friend/acquaintance. Regression modelling revealed more positive attitudes towards drug users in those with personal experience of drug misuse, (p<0.001), better knowledge of drugs (p=0.001) and higher income (those earning >£50,000 per, annum compared to <£15K; p=0.01). Over half of respondents were not willing to pay anything for drug treatment indicating they did not value these treatments at all. Respondents were willing-to-pay most for community rehabilitation and least for methadone maintenance treatment. Qualitative analysis of open responses indicated many strong negative attitudes, doubts over the efficacy of methadone and consideration of addiction as self-inflicted. There was ambivalence with respondents weighing up negative feelings towards treatment against societal benefit.
CONCLUSIONS: There is a gap between public attitudes and evidence regarding drug treatment. Findings suggest a way forward might be to develop and evaluate treatment that integrates ORT with a community rehabilitative approach. Evaluation of public engagement/education to improve knowledge of drug treatment effectiveness is recommended.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attitudes; Drug treatment approaches; Public opinion; Treatment policy

Mesh:

Substances:

Year:  2013        PMID: 24332456     DOI: 10.1016/j.drugpo.2013.11.001

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  8 in total

1.  Towards greater understanding of addiction stigma: Intersectionality with race/ethnicity and gender.

Authors:  Magdalena Kulesza; Mauri Matsuda; Jason J Ramirez; Alexandra J Werntz; Bethany A Teachman; Kristen P Lindgren
Journal:  Drug Alcohol Depend       Date:  2016-10-21       Impact factor: 4.492

2.  Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.

Authors:  B Levi Bolin; William W Stoops; Jeremy P Sites; Craig R Rush
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

3.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

4.  Correlates of public support toward federal funding for harm reduction strategies.

Authors:  Magdalena Kulesza; Bethany A Teachman; Alexandra J Werntz; Melissa L Gasser; Kristen P Lindgren
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-06-30

5.  "Don't Judge a Book Its Cover": A Qualitative Study of Methadone Patients' Experiences of Stigma.

Authors:  Julia Woo; Anuja Bhalerao; Monica Bawor; Meha Bhatt; Brittany Dennis; Natalia Mouravska; Laura Zielinski; Zainab Samaan
Journal:  Subst Abuse       Date:  2017-03-23

6.  Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.

Authors:  Paxton Bach; Daniel Hartung
Journal:  Addict Sci Clin Pract       Date:  2019-09-02

7.  A Community-Based Investigation of Stigma Toward Individuals Receiving Methadone Maintenance Treatment in China: A Randomized Case Vignette Study.

Authors:  Qijian Deng; Maorong Hu; Fang Yu; Qiaosheng Liu; Wei Hao; Qiuxia Wu; Tao Luo
Journal:  Front Psychiatry       Date:  2020-11-25       Impact factor: 4.157

8.  Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder.

Authors:  Alice Fiddian-Green; Aline Gubrium; Calla Harrington; Elizabeth A Evans
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.